Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Salt of dihydrosanguinarine derivative

A dihydrosanguinarine and drug technology, applied in the field of dihydrosanguinarine organic acid salts and its pharmaceutical application, can solve problems such as adverse reactions, drug resistance, and unsatisfactory drug treatment effects, and achieve practical therapeutic activity Effect

Inactive Publication Date: 2013-10-30
SHANGHAI YIZHI MEDICAL TECH
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] For now, although there are many kinds of drugs for the treatment of hepatitis B virus infection, these existing drugs are easy to cause multiple and severe adverse reactions, and some produce drug resistance, and the therapeutic effect of the existing drugs is still not enough. ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salt of dihydrosanguinarine derivative
  • Salt of dihydrosanguinarine derivative
  • Salt of dihydrosanguinarine derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Dihydrosanguinarine fumarate

[0048] Dissolve 3.35 g (0.01 mol) of the compound dihydrosanguinarine and 1.17 g (0.01 mol) of fumaric acid in 80 ml of boiling ethanol. The hot solution was filtered through diatomaceous earth, then slowly cooled under gentle stirring, and stood for several hours in a temperature environment of 0-5°C, dihydrosanguinarine fumarate crystals were precipitated, and dihydrosanguinarine was filtered out The fumarate salt crystals were washed with ethanol and dried under vacuum at 50°C to yield 4.48 g of product.

Embodiment 2

[0050] Dihydrosanguinarine Fumarate

[0051] Stir 3.35 g of the compound dihydrosanguinarine fumarate and 1.17 g of fumaric acid in 80 ml of refluxing ethanol until all the solids are dissolved. Add activated carbon, filter the hot solution through diatomaceous earth, and cool down to room temperature while stirring. Stand for several hours in a temperature environment of 0-5°C, precipitate dihydrosanguinarine fumarate crystals, filter out dihydrosanguinarine fumarate crystals, wash with ethanol and dry under vacuum at 50°C , 4.47 g of product were obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to fumarate or pharmacological acceptable solvates of dihydrosanguinarine and derivatives of the dihydrosanguinarine as well as an application of the fumarate or pharmacological acceptable solvates to the preparation of drugs for treating hepatitis B.

Description

field of invention [0001] The invention relates to the field of medicinal chemistry, in particular, the invention relates to dihydrosanguinarine organic acid salt and its pharmaceutical application. Background technique [0002] For now, although there are many kinds of drugs for the treatment of hepatitis B virus infection, these existing drugs are easy to cause multiple and severe adverse reactions, and some produce drug resistance, and the therapeutic effect of the existing drugs is still not enough. ideal. Chinese patent application publication number CN101084906A describes some active compounds for treating hepatitis B. Contents of the invention [0003] The present invention discloses some new compounds, preparation methods of these compounds, pharmaceutical compositions containing these compounds and pharmaceutical applications of these compounds and compositions. [0004] These compounds exhibit good water solubility stability and solid form stability. Some of t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D491/153A61K31/4741A61P1/16A61P31/20
Inventor 不公告发明人
Owner SHANGHAI YIZHI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com